tiprankstipranks
Qualigen Therapeutics Inc (QLGN)
NASDAQ:QLGN
US Market

Qualigen Therapeutics (QLGN) Income Statement

Compare
638 Followers

Qualigen Therapeutics Income Statement

Last quarter (Q3 2024), Qualigen Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Qualigen Therapeutics's net income was $-1.79M. See Qualigen Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Mar 20
Total Revenue
$ 5.20M$ 4.98M$ 5.65M$ 4.31M$ 5.56M
Gross Profit
$ -4.50K$ 680.80K$ 1.32M$ -2.88M$ 1.58M
Operating Expenses
$ 6.10M$ 18.62M$ 23.98M$ 17.40M$ 3.08M
Depreciation and Amortization
$ 4.50K$ 12.16K$ 322.06K$ 138.65K$ 111.38K
EBITDA
$ -11.30M$ -13.84M$ -22.66M$ -11.16M$ -10.02M
Operating Income
$ -11.30M$ -17.94M$ -22.66M$ -11.30M$ -1.50M
Other Income/Expenses
$ -1.17M$ 872.81K$ 4.77M$ -7.74M$ 711.17K
Pretax Income
$ -12.48M$ -21.30M$ -17.89M$ -20.42M$ -1.78M
Net Income
$ -13.42M$ -21.03M$ -17.90M$ -20.42M$ -1.79M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.46$ -5.48$ -6.10$ -28.21$ -2.85
Diluted EPS
$ -2.46$ -5.48$ -6.10$ -28.21$ -2.85
Weighted Average Shares Outstanding
5.07M 3.84M 2.93M 723.72K 627.00K
Weighted Average Shares Outstanding (Diluted)
5.07M 3.84M 2.93M 723.72K 627.00K
Currency in USD

Qualigen Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis